Evidence map›Paper›PMID 32655583›Full record

ArticleFrontiers in immunology

Vitamin D Supplementation: A Potential Approach for Coronavirus/COVID-19 Therapeutics?

John F Arboleda, Silvio Urcuqui-Inchima

Abstract read
In one paragraph

Article in Frontiers in immunology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Vitamin D-A prominent immunomodulator to prevent COVID-19 infection.International journal of rheumatic diseases · 2023
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Relation of vitamin D to COVID-19.Journal of virological methods · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. The role of micronutrient and immunomodulation effect in the vaccine era of COVID-19.Journal of the Chinese Medical Association : JCMA · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

John F ArboledaGroup of Immunovirology, Faculty of Medicine, University of Antioquia, Medellin, Colombia.
Silvio Urcuqui-InchimaGroup of Immunovirology, Faculty of Medicine, University of Antioquia, Medellin, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BetacoronavirusAngiotensin-Converting Enzyme 2Coronavirus InfectionsCOVID-19COVID-19 Drug TreatmentDietary SupplementsHost-Pathogen InteractionsHumansPandemicsPeptidyl-Dipeptidase APneumonia, ViralProtective AgentsRenin-Angiotensin SystemSARS-CoV-2Signal TransductionSpike Glycoprotein, CoronavirusACE2 protein, humanAngiotensin-Converting Enzyme 2Peptidyl-Dipeptidase AProtective AgentsSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Vitamin DVitaminsanti-inflammatoryantiviralCOVID-19SARS-Cov-2vitamin D

Identifiers

PMID32655583
PMCPMC7324720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.